ESMO 2023 Janssen satellite symposium "Transforming treatment approaches for patients with EGFR-mutant NSCLC"

Learning objective:         

After watching this broadcast, participants should be able to:

• Evaluate the latest updates in the management of EGFR-mutant NSCLC 
• Reflect on recent evidence and expert perspectives on the treatment of EGFR exon 20 insertion mutations in NSCLC
• Discuss how these advances will impact daily clinical practice

Faculty:

• Luis Paz-Ares (ES)
• Antonio Passaro (IT)
• Nicolas Girard (FR)
• Joshua Sabari (US)
• Natasha Leighl (CA)

The content of the following has been certified by the CPD Certification Service as conforming to continuing professional development principles.

You can claim 1.5 credits for this activity.

Please make a note of the below information to claim your points.

Name of activity: Transforming treatment approaches for patients with EGFR-mutant NSCLC, Sunday 22^nd October 2023. Madrid.

Certificate number: 48327

Date of activity: October 2023

CPD Provider: Sciterion 013096

CPD certification has been approved in principle.